Singular Journal - Securities house

The use of the Pfizer vaccine | December 7 Weekly Excerpt

 Weekly summary from October 30 to November 4

  • The U.S. equity market closes the week in positive territory. The three main Wall Street indexes set new all-time highs.
  • In Europe, the main financial markets closed the week in positive territory.

To be taken into account

  • Investors will be watching for new proposals for a new fiscal stimulus. They will be involved, Democrats and Republicans considering that government funding for nearly all federal agencies expires on December 11. 
  • It will be an important week for news about Pfizer's Covid-19 vaccine. In the United States, the FDA is scheduled to meet this Thursday, December 10, to authorize the use of Pfizer's vaccine. In the UK, the vaccine is expected to be available this week for high-risk groups.
  • In Europe, the focus will be on the meeting of the representatives of the European Union countries to try to give the green light to the new 1.8 billion euro spending package to help the economies affected by COVID-19. 
  • The United Kingdom and the European Union are very close to reaching a trade agreement after achieving a breakthrough on fishing rights.
  • It will be an interesting week for the IPO (initial public offering) market, companies such as DoorDash (DASH), Airbnb (ABNB), Hydrofarm Holdings (HYFM), Certara (CERT) and PubMatic (PUBM) are among the debutants.
  • Tension between the United States and China is increasing. According to a Reuters report, Washington is preparing sanctions for at least a dozen Chinese authorities for their alleged role in the disqualification of several elected opposition parliamentarians in Hong Kong.
  • The Serum Institute of India has applied for emergency use authorization for AstraZeneca's Covid-19 vaccine. One hundred million doses of vaccine would be ready for distribution in India this month.

To learn more, leave us your contact information and we will contact you.

Subscribe to continue reading

Read all content without limits

Subscribe here